| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/14/2010 | WO2010051634A1 Human progenitor t-cells |
| 05/14/2010 | WO2010023544A4 Compositions and methods for delivery of protein-coding rnas to correct mitochondrial dysfunction |
| 05/14/2010 | WO2010013906A3 Method for separating highly active stem cells from human stem cells and highly active stem cells separated thereby |
| 05/14/2010 | WO2010006072A3 Mtor modulators and uses thereof |
| 05/14/2010 | WO2009155301A3 Multipotent neural cells |
| 05/14/2010 | WO2009152485A3 Methods of cell-based technologies |
| 05/14/2010 | CA2742622A1 Human progenitor t-cells |
| 05/14/2010 | CA2742610A1 Compositions and methods for modulating cell-cell fusion via intermediate-conductance calcium-activated potassium channels |
| 05/14/2010 | CA2742583A1 Stem cell aggregate suspension compositions and methods for differentiation thereof |
| 05/14/2010 | CA2742521A1 Hla-g polypeptides and pharmaceutical uses thereof |
| 05/14/2010 | CA2742517A1 Hla-g proteins and pharmaceutical uses thereof |
| 05/14/2010 | CA2741119A1 Methods and compositions for inactivating glutamine synthetase gene expression |
| 05/14/2010 | CA2741050A1 Erbb-3 (her3)-selective combination therapy |
| 05/14/2010 | CA2689726A1 Antibodies against gpi.alpha. |
| 05/13/2010 | US20100122382 Cell Cycle Genes and Related Methods |
| 05/13/2010 | US20100122380 Polypeptides having feruloyl esterase activity and polynucleotides encoding same |
| 05/13/2010 | US20100122378 Truncated alternan sucrase coding nucleic acid molecules |
| 05/13/2010 | US20100122377 Lunaria annua,cardamine graeca and teesdalia nudicaulis fae genes and their use in producing nervonic and eicosenoic acids in seed oils |
| 05/13/2010 | US20100122376 Methods of enhancing the resistance of plants to bacterial pathogens |
| 05/13/2010 | US20100122375 Compositions and methods for enhancing disease resistance in plants |
| 05/13/2010 | US20100122374 Disease resistance in plants by introducing transcription factor gene |
| 05/13/2010 | US20100122367 Dominant Gene Suppression Transgenes and Methods of Using Same |
| 05/13/2010 | US20100122365 Optimizing glycan processing in plants |
| 05/13/2010 | US20100122363 Certain human genomic DNA associated with total red-green colorblindness |
| 05/13/2010 | US20100122362 Cells expressing alpha-synuclein and uses therefor |
| 05/13/2010 | US20100122361 Humanisation of animals |
| 05/13/2010 | US20100122360 Organ regeneration method utilizing blastocyst complementation |
| 05/13/2010 | US20100122358 H-Chain-only antibodies |
| 05/13/2010 | US20100122356 Pig model for psoriasis |
| 05/13/2010 | US20100122355 Transgenic Reporter Mouse and Method for Use |
| 05/13/2010 | US20100122354 Cdc6s as modifiers of the pten/akt pathway and methods of use |
| 05/13/2010 | US20100121255 Compound |
| 05/13/2010 | US20100121135 Sperm cell separation methods and compositions |
| 05/13/2010 | US20100120893 Compositions and Methods for Inhibiting Expression of Transthyretin |
| 05/13/2010 | US20100120892 Methods and compositions for the inhibition of stat5 in prostate cancer cells |
| 05/13/2010 | US20100120891 Use of a galectin-1-targeted rnai-based approach for the treatment of cancer |
| 05/13/2010 | US20100120781 Novel Compounds for Treatment of Cancer and Disorders Associated with Angiogenesis Function |
| 05/13/2010 | US20100120750 Methods for inducing polyploidization of megakaryocytes and for treating blood and bone marrow diseases and disorders |
| 05/13/2010 | US20100120704 Cardiac glycosides to treat cystic fibrosis and other IL-8 dependent disorders |
| 05/13/2010 | US20100120700 Methods and compositions for treating cervical cancer |
| 05/13/2010 | US20100120695 Polypeptides that bind membrane proteins |
| 05/13/2010 | US20100120694 Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| 05/13/2010 | US20100120684 Mutants of interleukin- 1 receptor antagonist and uses thereof |
| 05/13/2010 | US20100120679 Targeting NBS1-ATM Interaction To Sensitize Cancer Cells To Radiotherapy And Chemotherapy |
| 05/13/2010 | US20100120677 Activity of recombinant equine follicle stimulating hormone |
| 05/13/2010 | US20100120675 Inhibitor of the uracil-dna glycosylase enzyme and uses thereof |
| 05/13/2010 | US20100120666 Methods of treatment using glycopegylated g-csf |
| 05/13/2010 | US20100120664 Modified coagulation factors with prolonged in vivo half-life |
| 05/13/2010 | US20100120663 Method for inducing thrombopoiesis |
| 05/13/2010 | US20100120634 Compatible display vector systems |
| 05/13/2010 | US20100120627 Genemap of the human genes associated with psoriasis |
| 05/13/2010 | US20100120620 Drought Responsive Promoters HVA22e and PLDdelta identified from Arabidopsis thaliana |
| 05/13/2010 | US20100120155 Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof |
| 05/13/2010 | US20100120153 N-glycosylation mutant of melanoma differentiation associated gene-7 |
| 05/13/2010 | US20100120152 Methods for expression of transgenes |
| 05/13/2010 | US20100120151 enables embryogenic tissue to be detected in vitro thus allows for early discading of non-embryonic tissue; antioxidant; inhibition or retardation of apoptotic processes; tablet or cream form as an antiaging agent; used in generating male sterile plants |
| 05/13/2010 | US20100120150 Method for preparing serum and serum preparation apparatus |
| 05/13/2010 | US20100120149 Cell aggregate-hydrogel-polymer scaffold complex for cartilage regeneration, method for the preparation thereof and composition comprising the same |
| 05/13/2010 | US20100120148 Method for decomposing biological tissue |
| 05/13/2010 | US20100120147 Antagonist of ligands and uses thereof |
| 05/13/2010 | US20100120146 Activator of signal transduction pathway |
| 05/13/2010 | US20100120145 Three-dimensional biocompatible skeleton structure containing nanoparticles |
| 05/13/2010 | US20100120144 Method of culturing cells |
| 05/13/2010 | US20100120143 Induction of apoptosis and cell growth inhibition by protein 4.33 |
| 05/13/2010 | US20100120142 Culture of human embryonic cells |
| 05/13/2010 | US20100120141 Screening methods for compounds that modulate the activity of G-protein coupled receptors |
| 05/13/2010 | US20100120136 Bioreactor for cell and tissue culture |
| 05/13/2010 | US20100120110 Cytochrome p450s and uses thereof |
| 05/13/2010 | US20100120093 Method of Producing Serum-Free Insulin-Free Factor VII |
| 05/13/2010 | US20100120092 Recombinant proteins and virus like particles comprising l and s polypeptides of avian hepadnaviridae and methods, nucleic acid constructs, vectors and host cells for producing same |
| 05/13/2010 | US20100120090 MAMMALIAN EXPRESSION VECTOR pUHAB |
| 05/13/2010 | US20100120089 A novel vector and expression cell line for mass production of recombinant protein and a process of producing recombinant protein using same |
| 05/13/2010 | US20100120079 Trans-Differentiation And Re-Differentiation Of Somatic Cells And Production Of Cells For Cell Therapies |
| 05/13/2010 | US20100120070 Precise efficacy assay methods for active agents including chemotherapeutic agents |
| 05/13/2010 | US20100120069 Multipotent/pluripotent cells and methods |
| 05/13/2010 | US20100120068 G-protein-conjugated receptor having altered ligand affinity, and use thereof |
| 05/13/2010 | US20100120066 Method for detecting interactions between two and more biological macromolecules |
| 05/13/2010 | US20100120030 Extracellular serine protease |
| 05/13/2010 | US20100120015 Method of collecting placental stem cells |
| 05/13/2010 | US20100120014 Stability Drying |
| 05/13/2010 | US20100119997 Method for production of mesenchymal cell, method for production of tooth, and mesenchymal cell for formation of tooth |
| 05/13/2010 | US20100119690 Nucleotide sequences and corresponding polypeptides conferring modulated plant size and biomass in plants |
| 05/13/2010 | US20100119688 Increasing low light tolerance in plants |
| 05/13/2010 | US20100119588 Peptide for inhibition of influenza infection, inhibitor of influenza infection, liposome, and prophylactic/therapeutic agent for influenza |
| 05/13/2010 | US20100119579 Decellularized liver for repair of tissue and treatment of organ deficiency |
| 05/13/2010 | US20100119575 Osteogenic composite matrix, method for the production thereof and implant and scaffold for tissue engineering provided with a coating formed by said osteogenic composite matrix |
| 05/13/2010 | US20100119556 Methods and compositions for modulating an immune response with immunogenic oligonucleotides |
| 05/13/2010 | US20100119550 Recombinant multivalent vaccine |
| 05/13/2010 | US20100119546 Vaccine against african horse sickness virus |
| 05/13/2010 | US20100119545 Modified vaccinia ankara virus variant |
| 05/13/2010 | US20100119543 Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
| 05/13/2010 | US20100119538 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof |
| 05/13/2010 | US20100119537 Tumor vaccine |
| 05/13/2010 | US20100119528 Transport of Biologically Active Molecules into a Cell, Mitochondrion, or Nucleus |
| 05/13/2010 | US20100119520 Monoclonal antibodies that neutralize anthrax toxins |
| 05/13/2010 | US20100119514 Antibodies Against Cancer |
| 05/13/2010 | US20100119513 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
| 05/13/2010 | US20100119511 Light targeting molecules and uses thereof |
| 05/13/2010 | US20100119507 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/13/2010 | US20100119501 Method of delivering a protein into a cell |